Perspectives

Refinement and pressure testing of the launch strategy for a gene replacement therapy asset in a congenital rare disease therapy area, and competitor scenario planning exercise identifying key issues to address through the characterization of competitor launch scenarios

Payers have influence at a number of points across a brand's lifecycle. Understanding and managing the impact of this influence is key to unlocking an intervention's commercial potential. We've created a roadmap that outlines the different stages that payers can influence and outlines strategic considerations for brand teams.

Building an EMEA strategic brand plan for an autologous chimeric antigen receptor (CAR) T-cell therapy asset launch in multiple myeloma that effectively conveyed the unique considerations related to the product and the process aspects of launch strategy commercialization

It goes without saying that strategic planning is an important determinant of the success of any asset, brand or portfolio. Done well it can set direction, shape performance, provide focus for the organization and enable thoughtful allocation of resources. But add in the reality of project management, team alignment, coordination across geographies, review meetings, slide development, rehearsals and often the sheer length of the process, and it can sometimes start to feel like an obstacle to implementation or getting on with the day job.